Skip to main content
. 2022 May 28;12(6):888. doi: 10.3390/jpm12060888

Figure 2.

Figure 2

Immune-related adverse event (IrAE) group included eight patients who developed irAEs after 3 weeks. (a) Changes in proportions of circulating B cells are represented as the percentage of total peripheral blood mononuclear cells (PBMCs). (b) Changes in proportions of CD21lo B cells. All data represent the mean ± standard error of mean (SEM). * p < 0.05 by two-tailed Wilcoxon signed-rank test.